Cart
sales@molnova.com
1-Phenyloctane
CAS No. 2189-60-8
1-Phenyloctane( —— )
Catalog No. M28960 CAS No. 2189-60-8
1-Phenyloctane enhances the liquid-phase exfoliation of graphene in organic solvents.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 32 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 43 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 50MG | 107 | In Stock |
|
| 100MG | 160 | In Stock |
|
| 200MG | 241 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-Phenyloctane
-
NoteResearch use only, not for human use.
-
Brief Description1-Phenyloctane enhances the liquid-phase exfoliation of graphene in organic solvents.
-
Description1-Phenyloctane enhances the liquid-phase exfoliation of graphene in organic solvents.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2189-60-8
-
Formula Weight190.33
-
Molecular FormulaC14H22
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCCc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhou et al. The safety profile of a selective EGFR TKI epitinib (HMPL-813) in patients with advanced solid tumors and preliminary clinical efficacy in EGFRm+ NSCLC patients with brain metastasis. Journal of Clinical Oncology 2016 34:15_suppl, e20502-e20502
molnova catalog
related products
-
Meclocycline sulfosa...
Meclocycline (INN) is a tetracycline antibiotic. It is used topically (i.e. for skin infections) as it is totally insoluble in water and may cause liver and kidney damage if given systemically.
-
Cytidine 5'-triphosp...
Cytidine 5'-triphosphate (CTP) is a pyrimidine nucleoside triphosphate that is involved in a variety of biochemical reactions. It is used in the synthesis of RNA by RNA polymerases.
-
cAMP-Dependent Prote...
PKI(5-22)amide is the active inhibitory fragment of the inhibitor of the cyclic AMP-dependent protein kinase (PKA). PKI(5-22)amide inhibits PKA activation, but fails to attenuate homologous desensitization of CRF1 receptors.
